BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17891183)

  • 21. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
    Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
    Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of NFAT signal by p53-K120R mutant.
    Shinmen N; Koshida T; Kumazawa T; Sato K; Shimada H; Matsutani T; Iwadate Y; Takiguchi M; Hiwasa T
    FEBS Lett; 2009 Jun; 583(12):1916-22. PubMed ID: 19416725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modifications of human histone H3 variants during mitosis.
    Garcia BA; Barber CM; Hake SB; Ptak C; Turner FB; Busby SA; Shabanowitz J; Moran RG; Allis CD; Hunt DF
    Biochemistry; 2005 Oct; 44(39):13202-13. PubMed ID: 16185088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological significance of protein modifications in aging and calorie restriction.
    Nakamura A; Kawakami K; Kametani F; Nakamoto H; Goto S
    Ann N Y Acad Sci; 2010 Jun; 1197():33-9. PubMed ID: 20536830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a code embedded in proteins that is based on post-translational modifications?
    Sims RJ; Reinberg D
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):815-20. PubMed ID: 18784729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal histone modifications in models of levodopa-induced dyskinesia.
    Nicholas AP; Lubin FD; Hallett PJ; Vattem P; Ravenscroft P; Bezard E; Zhou S; Fox SH; Brotchie JM; Sweatt JD; Standaert DG
    J Neurochem; 2008 Jul; 106(1):486-94. PubMed ID: 18410512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal and paternal alleles exhibit differential histone methylation and acetylation at maize imprinted genes.
    Haun WJ; Springer NM
    Plant J; 2008 Dec; 56(6):903-12. PubMed ID: 18694457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of serine-10 of histone H3 shields modified lysine-9 selectively during mitosis.
    Jeong YS; Cho S; Park JS; Ko Y; Kang YK
    Genes Cells; 2010 Mar; 15(3):181-92. PubMed ID: 20070858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation.
    Kawauchi K; Araki K; Tobiume K; Tanaka N
    Biochem Biophys Res Commun; 2008 Jul; 372(1):137-41. PubMed ID: 18477470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of histone H3 tails with combinatorial lysine modifications under the reprogrammed genetic code for the investigation on epigenetic markers.
    Kang TJ; Yuzawa S; Suga H
    Chem Biol; 2008 Nov; 15(11):1166-74. PubMed ID: 19022177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H3K9 acetylation and radial chromatin positioning.
    Strasák L; Bártová E; Harnicarová A; Galiová G; Krejcí J; Kozubek S
    J Cell Physiol; 2009 Jul; 220(1):91-101. PubMed ID: 19248079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of tetramerisation on site-specific post-translational modifications of p53: comparison of human and murine p53 tumor suppressor protein.
    Warnock LJ; Knox A; Mee TR; Raines SA; Milner J
    Cancer Biol Ther; 2008 Sep; 7(9):1481-9. PubMed ID: 18769132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased genomic instability and altered chromosomal protein phosphorylation timing in HRAS-transformed mouse fibroblasts.
    Dunn KL; He S; Wark L; Delcuve GP; Sun JM; Yu Chen H; Mai S; Davie JR
    Genes Chromosomes Cancer; 2009 May; 48(5):397-409. PubMed ID: 19191262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation.
    Dong Z; Bode AM
    Mol Carcinog; 2006 Jun; 45(6):416-21. PubMed ID: 16637065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
    Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
    J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
    Olsson A; Manzl C; Strasser A; Villunger A
    Cell Death Differ; 2007 Sep; 14(9):1561-75. PubMed ID: 17627286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone inhibits phosphorylation of histone H3 at serine 10.
    Hasegawa Y; Tomita K; Watanabe M; Yamasaki A; Sano H; Hitsuda Y; Shimizu E
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1049-55. PubMed ID: 16165091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 induces distinct epigenetic states at its direct target promoters.
    Vrba L; Junk DJ; Novak P; Futscher BW
    BMC Genomics; 2008 Oct; 9():486. PubMed ID: 18922183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 Ser15 phosphorylation and histone modifications contribute to IR-induced miR-34a transcription in mammary epithelial cells.
    Wang B; Li D; Kovalchuk O
    Cell Cycle; 2013 Jul; 12(13):2073-83. PubMed ID: 23759592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.